297 related articles for article (PubMed ID: 29536202)
1. Multiomics tools for the diagnosis and treatment of rare neurological disease.
Crowther LM; Poms M; Plecko B
J Inherit Metab Dis; 2018 May; 41(3):425-434. PubMed ID: 29536202
[TBL] [Abstract][Full Text] [Related]
2. Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review.
Graham E; Lee J; Price M; Tarailo-Graovac M; Matthews A; Engelke U; Tang J; Kluijtmans LAJ; Wevers RA; Wasserman WW; van Karnebeek CDM; Mostafavi S
J Inherit Metab Dis; 2018 May; 41(3):435-445. PubMed ID: 29721916
[TBL] [Abstract][Full Text] [Related]
3. Discovery and development of biomarkers of neurological disease.
Dunckley T; Coon KD; Stephan DA
Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in metabolomics in neurological disease, and future perspectives.
Zhang AH; Sun H; Wang XJ
Anal Bioanal Chem; 2013 Oct; 405(25):8143-50. PubMed ID: 23715678
[TBL] [Abstract][Full Text] [Related]
5. Addressing challenges in the diagnosis and treatment of rare genetic diseases.
Boycott KM; Ardigó D
Nat Rev Drug Discov; 2018 Mar; 17(3):151-152. PubMed ID: 29242613
[TBL] [Abstract][Full Text] [Related]
6. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting.
Bonomo R; Cavaletti G; Skene DJ
Expert Rev Neurother; 2020 Jul; 20(7):725-738. PubMed ID: 32538242
[TBL] [Abstract][Full Text] [Related]
8. Next Generation Diagnostics for Rare Neurological Diseases: The Future is Here.
Innes AM; Boycott KM
Can J Neurol Sci; 2014 May; 41(3):299-300. PubMed ID: 24718813
[No Abstract] [Full Text] [Related]
9. Next-generation sequencing applied to rare diseases genomics.
Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
[TBL] [Abstract][Full Text] [Related]
10. Rare neurological diseases: a practical approach to management.
Dani KA; Murray LJ; Razvi S
Pract Neurol; 2013 Aug; 13(4):219-27. PubMed ID: 23487805
[TBL] [Abstract][Full Text] [Related]
11. Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics.
Hartin SN; Means JC; Alaimo JT; Younger ST
Mol Med; 2020 Nov; 26(1):117. PubMed ID: 33238891
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights from combining genomics with metabolomics.
Drenos F
Curr Opin Lipidol; 2017 Apr; 28(2):99-103. PubMed ID: 28092275
[TBL] [Abstract][Full Text] [Related]
13. Rare neurological diseases: a united approach is needed.
The Lancet Neurology
Lancet Neurol; 2011 Feb; 10(2):109. PubMed ID: 21256450
[No Abstract] [Full Text] [Related]
14. Leveraging network analytics to infer patient syndrome and identify causal genes in rare disease cases.
Krämer A; Shah S; Rebres RA; Tang S; Richards DR
BMC Genomics; 2017 Aug; 18(Suppl 5):551. PubMed ID: 28812537
[TBL] [Abstract][Full Text] [Related]
15. Prioritization of Variants Detected by Next Generation Sequencing According to the Mutation Tolerance and Mutational Architecture of the Corresponding Genes.
Roca I; Fernández-Marmiesse A; Gouveia S; Segovia M; Couce ML
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29861492
[TBL] [Abstract][Full Text] [Related]
16. Use of "omics" technologies to dissect neurologic disease.
Tosto G; Reitz C
Handb Clin Neurol; 2016; 138():91-106. PubMed ID: 27637954
[TBL] [Abstract][Full Text] [Related]
17. Integrative omics approaches to advance rare disease diagnostics.
Smirnov D; Konstantinovskiy N; Prokisch H
J Inherit Metab Dis; 2023 Sep; 46(5):824-838. PubMed ID: 37553850
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics: moving to the clinic.
Nordström A; Lewensohn R
J Neuroimmune Pharmacol; 2010 Mar; 5(1):4-17. PubMed ID: 19399626
[TBL] [Abstract][Full Text] [Related]
19. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
